Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
HT-100
DRUG
3 trials
Sponsors
Processa Pharmaceuticals
, Akashi Therapeutics
Conditions
Duchenne Muscular Dystrophy
Phase 1
Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of HT-100 in Duchenne Muscular Dystrophy
Terminated
NCT01847573
Processa Pharmaceuticals
Duchenne Muscular Dystrophy
Start: 2013-05-31
End: 2016-03-30
Updated: 2020-09-03
Phase 2
Open Label Extension Study of HT-100 in Patients With DMD
Terminated
NCT01978366
Processa Pharmaceuticals
Duchenne Muscular Dystrophy
Start: 2013-10-31
End: 2016-04-30
Updated: 2020-09-03
HT-100 Long-term Study in DMD Patients Who Completed HALO-DMD-02
Terminated
NCT02525302
Akashi Therapeutics
Duchenne Muscular Dystrophy
Start: 2015-05-31
End: 2016-12-30
Updated: 2019-03-12